| Product Code: ETC8533454 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Netherlands continues to witness a steady increase in blood plasma derivative import shipments, with key exporters in 2024 being the USA, Germany, Ireland, Italy, and Switzerland. The market shows moderate concentration levels with a Herfindahl-Hirschman Index (HHI) remaining stable. A strong compound annual growth rate (CAGR) of 7.8% from 2020 to 2024 indicates a healthy market expansion. Notably, the growth rate spiked at an impressive 30.12% from 2023 to 2024, highlighting a significant surge in demand for these vital medical products.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Blood Plasma Derivative Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Blood Plasma Derivative Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Blood Plasma Derivative Market - Industry Life Cycle |
3.4 Netherlands Blood Plasma Derivative Market - Porter's Five Forces |
3.5 Netherlands Blood Plasma Derivative Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Netherlands Blood Plasma Derivative Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Netherlands Blood Plasma Derivative Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Netherlands Blood Plasma Derivative Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring blood plasma derivatives |
4.2.2 Growing awareness about the benefits of blood plasma derivative therapies |
4.2.3 Technological advancements in the production and purification of blood plasma derivatives |
4.3 Market Restraints |
4.3.1 Stringent regulations and quality standards for blood plasma derivative products |
4.3.2 High cost associated with the production and distribution of blood plasma derivatives |
4.3.3 Limited availability of plasma donors and collection centers |
5 Netherlands Blood Plasma Derivative Market Trends |
6 Netherlands Blood Plasma Derivative Market, By Types |
6.1 Netherlands Blood Plasma Derivative Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Blood Plasma Derivative Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Netherlands Blood Plasma Derivative Market Revenues & Volume, By Albumin, 2021- 2031F |
6.1.4 Netherlands Blood Plasma Derivative Market Revenues & Volume, By Factor VII, 2021- 2031F |
6.1.5 Netherlands Blood Plasma Derivative Market Revenues & Volume, By Factor IX concentrate, 2021- 2031F |
6.1.6 Netherlands Blood Plasma Derivative Market Revenues & Volume, By Anti-coagulation factor, 2021- 2031F |
6.1.7 Netherlands Blood Plasma Derivative Market Revenues & Volume, By Rh immunoglobulin, 2021- 2031F |
6.1.8 Netherlands Blood Plasma Derivative Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Netherlands Blood Plasma Derivative Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Blood Plasma Derivative Market Revenues & Volume, By Immunodeficiency Diseases, 2021- 2031F |
6.2.3 Netherlands Blood Plasma Derivative Market Revenues & Volume, By Bleeding Disorders, 2021- 2031F |
6.2.4 Netherlands Blood Plasma Derivative Market Revenues & Volume, By Liver Conditions, 2021- 2031F |
6.2.5 Netherlands Blood Plasma Derivative Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Netherlands Blood Plasma Derivative Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Blood Plasma Derivative Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Netherlands Blood Plasma Derivative Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 Netherlands Blood Plasma Derivative Market Revenues & Volume, By Transfusion Centers, 2021- 2031F |
7 Netherlands Blood Plasma Derivative Market Import-Export Trade Statistics |
7.1 Netherlands Blood Plasma Derivative Market Export to Major Countries |
7.2 Netherlands Blood Plasma Derivative Market Imports from Major Countries |
8 Netherlands Blood Plasma Derivative Market Key Performance Indicators |
8.1 Average selling price of blood plasma derivatives |
8.2 Number of new blood plasma derivative therapies introduced in the market |
8.3 Percentage of revenue invested in research and development for blood plasma derivative products |
9 Netherlands Blood Plasma Derivative Market - Opportunity Assessment |
9.1 Netherlands Blood Plasma Derivative Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Netherlands Blood Plasma Derivative Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Netherlands Blood Plasma Derivative Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Netherlands Blood Plasma Derivative Market - Competitive Landscape |
10.1 Netherlands Blood Plasma Derivative Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Blood Plasma Derivative Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here